From September 20, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.1 CNY | -0.09% | +2.42% | +15.02% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.02% | 6.83B | |
+16.80% | 8.33B | |
+3.59% | 7.73B | |
-6.75% | 3.78B | |
-4.32% | 3.76B | |
+4.41% | 1.45B | |
+20.28% | 1.05B | |
-13.51% | 882M | |
-15.73% | 778M | |
+2.88% | 727M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.